154 related articles for article (PubMed ID: 35084511)
41. 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.
Schwartz EL; Baptiste N; Megati S; Wadler S; Otter BA
Cancer Res; 1995 Aug; 55(16):3543-50. PubMed ID: 7627962
[TBL] [Abstract][Full Text] [Related]
42. Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer.
Hua D; Huang ZH; Mao Y; Deng JZ
World J Gastroenterol; 2007 Oct; 13(37):5030-4. PubMed ID: 17854149
[TBL] [Abstract][Full Text] [Related]
43. [Improved sensitivity of gastric carcinoma cells to fluorouracil-related drugs by transfection of thymidine phosphorylase gene].
Zhuo LJ; Gao MQ; Huang AM
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):330-3. PubMed ID: 21756828
[TBL] [Abstract][Full Text] [Related]
44. Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells.
Ko JC; Tsai MS; Chiu YF; Weng SH; Kuo YH; Lin YW
J Pharmacol Exp Ther; 2011 Jul; 338(1):184-94. PubMed ID: 21444628
[TBL] [Abstract][Full Text] [Related]
45. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy.
Soong R; Shah N; Salto-Tellez M; Tai BC; Soo RA; Han HC; Ng SS; Tan WL; Zeps N; Joseph D; Diasio RB; Iacopetta B
Ann Oncol; 2008 May; 19(5):915-9. PubMed ID: 18245778
[TBL] [Abstract][Full Text] [Related]
47. 5-Aza-2-deoxycytidine Enhances the Sensitivity of 5-Fluorouracil by Demethylation of the Thymidine Phosphorylase Promoter.
Nishizawa Y; Ikeda R; Yamamoto M; Kawahara K; Shinsato Y; Minami K; Nitta M; Terazono H; Akiyama SI; Furukawa T; Takeda Y
Anticancer Res; 2019 Aug; 39(8):4129-4136. PubMed ID: 31366497
[TBL] [Abstract][Full Text] [Related]
48. A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients.
Ranieri G; Grammatica L; Patruno R; Zito AF; Valerio P; Iacobellis S; Gadaleta C; Gasparini G; Ribatti D
J Cell Mol Med; 2007; 11(2):362-8. PubMed ID: 17378915
[TBL] [Abstract][Full Text] [Related]
49. The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix.
Hasegawa K; Okamoto H; Kawamura K; Kato R; Kobayashi Y; Sekiya T; Udagawa Y
Eur J Obstet Gynecol Reprod Biol; 2012 Jul; 163(1):67-70. PubMed ID: 22480411
[TBL] [Abstract][Full Text] [Related]
50. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
Koukourakis MI; Giatromanolaki A; Fountzilas G; Sivridis E; Gatter KC; Harris AL
Clin Cancer Res; 2000 Feb; 6(2):381-9. PubMed ID: 10690514
[TBL] [Abstract][Full Text] [Related]
51. Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha.
Braybrooke JP; Propper DJ; O'Byrne KJ; Koukourakis MI; Patterson AV; Houlbrook S; Love SD; Varcoe S; Taylor M; Ganesan TS; Talbot DC; Harris AL
Br J Cancer; 2000 Jul; 83(2):219-24. PubMed ID: 10901374
[TBL] [Abstract][Full Text] [Related]
52. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.
Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T
Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811
[TBL] [Abstract][Full Text] [Related]
53. The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells.
Mori R; Yoshida K; Futamura M; Suetsugu T; Shizu K; Tanahashi T; Tanaka Y; Matsuhashi N; Yamaguchi K
Gastric Cancer; 2019 May; 22(3):497-505. PubMed ID: 30276573
[TBL] [Abstract][Full Text] [Related]
54. Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells.
Yao Y; Kubota T; Sato K; Takeuchi H; Kitai R; Matsukawa S
J Neurooncol; 2005 May; 72(3):217-23. PubMed ID: 15937643
[TBL] [Abstract][Full Text] [Related]
55. Thymidine phosphorylase in cancer aggressiveness and chemoresistance.
Furukawa T; Tabata S; Yamamoto M; Kawahara K; Shinsato Y; Minami K; Shimokawa M; Akiyama SI
Pharmacol Res; 2018 Jun; 132():15-20. PubMed ID: 29604437
[TBL] [Abstract][Full Text] [Related]
56. Induction of thymidine phosphorylase expression by AZT contributes to enhancement of 5'-DFUR cytotoxicity.
Tsuneyoshi K; Haraguchi M; Hongye Z; Gotanda T; Tachiwada T; Sumizawa T; Furukawa T; Baba M; Akiyama S; Nakagawa M
Cancer Lett; 2006 Dec; 244(2):239-46. PubMed ID: 16457948
[TBL] [Abstract][Full Text] [Related]
57. Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Terashima M; Fujiwara H; Takagane A; Abe K; Irinoda T; Nakaya T; Yonezawa H; Oyama K; Saito K; Kanzaki N; Ohtani S; Nemoto T; Hoshino Y; Kogure M; Gotoh M
Gastric Cancer; 2003; 6 Suppl 1():71-81. PubMed ID: 12775024
[TBL] [Abstract][Full Text] [Related]
58. Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine.
Fuller RN; Kabagwira J; Vallejos PA; Folkerts AD; Wall NR
Onco Targets Ther; 2022; 15():1147-1160. PubMed ID: 36238134
[TBL] [Abstract][Full Text] [Related]
59. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
[TBL] [Abstract][Full Text] [Related]
60. Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer.
Boskos CS; Liacos C; Korkolis D; Aygerinos K; Lamproglou I; Terpos E; Stoupa E; Baltatzis G; Beroukas K; Papasavvas P; Dimopoulos MA; Bamias A
J Surg Oncol; 2010 Oct; 102(5):408-12. PubMed ID: 19877119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
